Radiology Medical News

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

111In-labeled KCCYSL peptide as an imaging probe for ErbB-2-expressing ovarian carcinomas
Journal of Labelled Compounds and Radiopharmaceuticals, 11/05/09

Deutscher SL et al. – Blocking studies with non–radiolabeled counterpart indicated a partial inhibition (41%) (P=0.04) in tumor uptake of 111In–DOTA–GSG–KCCYSL. In vivo tumor uptake of 111In–DOTA–GSG–KCCYSL was clearly evident through SPECT/CT images after 2 h post injection. These studies suggest the potential of this peptide as a radiopharmaceutical for imaging of ErbB–2–expressing ovarian tumors.

<< Previous
Qualitative assessment of ultrasound biomicroscopic images using...

Next >>
Intra- and interobserver reliabilities of two common radiographic...